Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India

(2016) Sunil S. Solomon et al.   PLoS One

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

(2015) Mark Sulkowski et al.   LANCET

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

(2015) Eric Lawitz et al.   LANCET

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study

(2015) Sunil Suhas Solomon et al.   LANCET INFECTIOUS DISEASES

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

(2015) Michael P. Curry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

(2015) Graham R. Foster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Examining non-AIDS mortality among people who inject drugs

(2014) Bradley M. Mathers et al.   AIDS

Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients

(2014) FA Gonzalez et al.   HIV MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treating Hepatitis C in Lower-Income Countries

(2014) Channa R. Jayasekera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality among people who inject drugs: a systematic review and meta-analysis

(2013) Bradley M Mathers et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B

(2013) Rohit Goyal et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Stability of liver fibrosis among HCV-infected injection drug users

(2012) Shruti H Mehta et al.   ANTIVIRAL THERAPY

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

“Normal” liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country

(2011) Kausik Das et al.   HEPATOLOGY

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

(2011) William Sievert et al.   LIVER INTERNATIONAL

Chronic Hepatitis C Infection

(2011) Hugo R. Rosen   NEW ENGLAND JOURNAL OF MEDICINE

Low Incidences of Human Immunodeficiency Virus and Hepatitis C Virus Infection and Declining Risk Behaviors in a Cohort of Injection Drug Users in Chennai, India

(2010) S. S. Solomon et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Mortality among injection drug users in Chennai, India (2005–2008)

(2009) Sunil S Solomon et al.   AIDS

Assessment of Liver Fibrosis by Transient Elastography in Persons with Hepatitis C Virus Infection or HIV–Hepatitis C Virus Coinfection

(2009) Gregory D. Kirk et al.   CLINICAL INFECTIOUS DISEASES

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

(2009) Alfredo Alberti   LIVER INTERNATIONAL

High Prevalence of HIV, HIV/Hepatitis C Virus Coinfection, and Risk Behaviors Among Injection Drug Users in Chennai, India: A Cause for Concern

(2008) Sunil S Solomon et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Environmental factors as disease accelerators during chronic hepatitis C

(2008) Ariane Mallat et al.   JOURNAL OF HEPATOLOGY